ANTI-INFECTIVE DRUGS ADVISORY COMMITTEE

April  26, 2001

Briefing Information

Aventis Pharma

Disclaimer

The statements contained in this document are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Ketek (telithromycin)    pdf   html

FDA Background Package    pdf   html

FDA Background Package Errata    pdf    html